Welmo raises ~¥680M to scale AI tools for Japan's elderly-care sector
What's the deal? Welmo, a Fukuoka-based startup building AI tools for Japan's healthcare and elderly care sector, has raised approximately ¥680M (roughly $4.5M) through a third-party share allocation. The round was led by Fujita TT Impact No.1 Investment Limited Partnership, with participation from individual investor Kuya Nishizaka and other corporate investors. Total funding to date now stands at about ¥5.56B.
Founded in 2013, Welmo develops the "Milmo Series" — an AI platform suite designed specifically for care workers, care managers, and nurses. Its products range from voice-recording AI summarisation and care plan generation to RPA for medical office tasks. The company has built a user network spanning 26,100 care facilities across Japan, claiming 84–100% market share in some regions.
Why now? Japan's demographic crisis is intensifying. The country has roughly 36 million people aged 65 or older, with about seven million certified as needing care. Chronic staff shortages mean caregivers have less time for the people they serve.
Government policy is catching up. Welmo's founder and CEO Yusuke KanoDealroom has a profile for this one. Try Dealroom → has pushed for regulatory changes that now position care technology not as a nice-to-have but as essential infrastructure. In April 2026, a joint research project with the International University of Health and Welfare was accepted for government research funding — a sign of growing institutional support.
The fresh capital will go toward hiring sales and customer success staff nationwide, enhancing AI features across the Milmo Series, continuing academic research partnerships, and recruiting domain experts alongside AI talent.
What could go wrong? Elderly care is a heavily regulated, traditionally slow-moving sector. Convincing frontline workers to adopt AI tools — and stick with them — requires intensive hand-holding, which is exactly why Welmo is prioritising customer success hires over pure product development. Scaling that human infrastructure is expensive and hard to do quickly.
There's also a design tension inherent in Welmo's approach: it insists that AI should support, never replace, human judgment. That philosophy builds trust but may limit how much efficiency the tools can actually deliver.
The signal: Welmo, now at breakout stage according to Dealroom, has amassed roughly ¥5.56B in total funding — substantial for a care-tech startup operating in a sector not typically known for attracting venture capital. With a user network of 26,100 facilities and regional market shares as high as 100%, the company has built the kind of distribution moat that could prove difficult for later entrants to replicate as Japan's care workforce shortage deepens.
Read more: PR Times
